[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353024-105":59,"doc-detail-353024-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ectopic-breast-cancer-in-vulva-and-other-non-axillary-sites-a-systematic-review","Ectopic breast cancer in vulva and other non-axillary sites - a systematic review","","Ectopic breast cancer (EBC) is a rare malignancy arising along the embryological milk line, accounting for about 0.3–0.6% of breast cancers. Axillary EBC is relatively well characterized, whereas non-axillary EBC has poorly defined clinical features and management. This systematic review synthesizes clinical presentation, histopathology, treatment, and outcomes to refine site-adapted treatment strategies and support consistent evidence-based care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ectopic-breast-cancer-in-vulva-and-other-non-axillary-sites-a-systematic-review/353024/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ectopic-breast-cancer-in-vulva-and-other-non-axillary-sites-a-systematic-review/353024.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is ectopic breast cancer, and why is non-axillary EBC difficult to manage?","Question",{"text":112,"@type":113},"Ectopic breast cancer arises from ectopic breast tissue along the embryological milk line. Non-axillary EBC remains poorly defined, with presentations that can mimic benign conditions and with limited standardized diagnostic and therapeutic pathways.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the systematic review conducted and what databases were searched?",{"text":117,"@type":113},"The review followed PRISMA 2020 guidelines and was registered with PROSPERO. Searches were performed in PubMed, Ovid MEDLINE, Embase, Scopus, and the Cochrane Library up to April 2025.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings on histology, receptor status, and outcomes?",{"text":121,"@type":113},"The review included 61 studies with 63 patients, predominantly vulvar cases. Invasive ductal adenocarcinoma was the most common histologic subtype, estrogen receptor positivity was frequent, lymph node involvement was reported in about half, and recurrence and mortality rates among cases with follow-up were 18.0% and 16.0%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353024,1790315120,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Loo and Hwang World Journal of Surgical Oncology (2026) 24:240  \n[https://doi.org/10.1186/s12957-026-04358-8](https://doi.org/10.1186/s12957-026-04358-8)  \nWorld Journal of Surgical Oncology  \nREVIEW Open Access  \nEctopic breast cancer in vulva and other non- axillary sites: a systematic review  \nKai Hui Loo 1,2* and Mei-ju Hwang2  \nAbstract  \nBackground Ectopic breast cancer (EBC) is a rare malignancy (0 .3–0. 6% of all breast cancers) that arises along the embryological milk line. While axillary EBC is better characterised and typically managed similarly to orthotopic breast cancer, the clinical features and management of non-axillary EBC remain poorly defined.  \nAim To synthesise available data on the clinical presentation, histopathology, management, and outcomes of nonaxillary EBC to refine treatment strategies.  \nMethods A systematic review of case reports and case series was conducted following PRISMA 2020 guidelines and registered with PROSPERO (CRD420251035771) . PubMed, Ovid MEDLINE, Embase, Scopus, and Cochrane Library were searched up to April 2025. Study quality was assessed using the JBI checklist. Data were analysed descriptively using Microsoft Excel, focusing on clinical presentation, diagnosis, histopathology, treatment, and outcomes.  \nResults Sixty-one studies (63 patients) were included: 37 vulvar and 26 non-vulvar cases. Median age at diagnosis was 62. Lesions typically presented as painless nodules, with ulceration prompting attention. Invasive ductaladenocarcinoma was the most common histological subtype (39 . 7%), and oestrogen receptor positivity (82 . 5%) was frequent. Lymph node involvement was reported in 50. 8% of cases. Organ metastases commonly involved bone, lung, and liver. Surgery was the main treatment, with adjuvant systemic therapy. Among cases with available follow-up (n = 50), recurrence and mortality rates were 18. 0%(n = 9) and 16. 0%(n = 8), respectively. Follow-up methods were poorly documented.  \nConclusion Non-axillary EBC shares clinical and pathological characteristics with orthotopic breast cancer. Multidisciplinary, site-adapted approach is recommended with applying breast cancer principles to systemic management. Increased clinical awareness and more consistent reporting are crucial to optimise future care and outcomes.  \nKeywords Ectopic breast cancer, Vulvar ectopic breast cancer, Non-axillary ectopic breast cancer, Extra-mammary breast cancer, Systematic review, Embryological remnants  \n*Correspondence: Kai Hui Loo[kai.loo@wales.nhs.uk](kai.loo@wales.nhs.uk)  \n1University of Edinburgh, Edinburgh, UK  \n2Department of General Surgery, Ysbyty Gwynedd, Betsi Cadwaladr University Health Board, Bangor, UK  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nLoo and Hwang World Journal of Surgical Oncology (2026) 24:240  \nBackground  \nEctopic breast tissue (EBT), first described by Hartung in 1872, is also known as supernumerary or aberrant breast tissue. It refers to breast tissue found outside its normal anatomical location on the anterior chest wall between the second and sixth ribs. Typically developing along the embryonic milk line from","cbCaivYn1pwbgR3S","https://ap.wps.com/l/cbCaivYn1pwbgR3S","pdf",1915661,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Ectopic breast tissue and EBC overview\n## Clinical challenges in non-axillary EBC\n## Rationale for this review\n# Methods","[{\"question\":\"What is ectopic breast cancer, and why is non-axillary EBC difficult to manage?\",\"answer\":\"Ectopic breast cancer arises from ectopic breast tissue along the embryological milk line. Non-axillary EBC remains poorly defined, with presentations that can mimic benign conditions and with limited standardized diagnostic and therapeutic pathways.\"},{\"question\":\"How was the systematic review conducted and what databases were searched?\",\"answer\":\"The review followed PRISMA 2020 guidelines and was registered with PROSPERO. Searches were performed in PubMed, Ovid MEDLINE, Embase, Scopus, and the Cochrane Library up to April 2025.\"},{\"question\":\"What were the main findings on histology, receptor status, and outcomes?\",\"answer\":\"The review included 61 studies with 63 patients, predominantly vulvar cases. Invasive ductal adenocarcinoma was the most common histologic subtype, estrogen receptor positivity was frequent, lymph node involvement was reported in about half, and recurrence and mortality rates among cases with follow-up were 18.0% and 16.0%.\"}]","Ectopic breast cancer in vulva and other non-axillary sites - a systematic review | PDF",1790102617,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e929733bebe07073e85e1613e6469be8.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff2a623acb7015bfdad3956c224c4df3.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4eaec0a1e7a3c1bdc56de489506b55a1.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8539261be6f2a36e763a60ade703ff0.webp",980,1306]